Friday, 10 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Tech and Science > Extraordinary pictures show what a common antibiotic does to E. coli
Tech and Science

Extraordinary pictures show what a common antibiotic does to E. coli

Last updated: September 29, 2025 2:09 pm
Share
Extraordinary pictures show what a common antibiotic does to E. coli
SHARE

An E. coli bacterium before and after treatment with polymyxin B

The top image depicts untreated E. coli; the bottom image shows the same bacterium after 90 minutes of exposure to the antibiotic polymyxin B.

Carolina Borrelli, Edward Douglas et al./Nature Microbiology

The mechanism by which polymyxins, a class of antibiotics, breach the defenses of bacteria has been revealed through high-resolution microscopy, offering new insights for developing treatments against drug-resistant infections.

Polymyxins are typically reserved as last-line treatments for certain gram-negative bacteria responsible for serious infections such as pneumonia, meningitis, and typhoid fever. As noted by Andrew Edwards from Imperial College London, “The top three World Health Organization priority pathogens are all gram-negative bacteria, reflecting their complex cell envelope.”

These bacteria possess an outer membrane made of lipopolysaccharides, which functions as a barrier. While it’s known that polymyxins target this layer, the specific mechanisms by which they disrupt it and kill the bacteria were previously unclear. Additionally, it was uncertain why these drugs sometimes failed.

In research conducted by Edwards and his team, they employed biochemical assays and atomic force microscopy to discover that polymyxin B, one of the two polymyxins approved for clinical use, triggers the formation of bulges on the surface of gram-negative bacteria like E. coli.

Shortly after the appearance of these protrusions, the bacteria began shedding lipopolysaccharides, evident in the surrounding solution.

The team concluded that the presence of the antibiotic prompts the bacteria to accelerate the incorporation of lipopolysaccharide “bricks” into their protective exterior. However, this rapid construction coincides with the loss of some bricks, creating temporary vulnerabilities for the antibiotic to penetrate and kill the cells.

See also  Does this sculpted head show an ancient hunter-gatherer's hairstyle?

“The antibiotics act like a crowbar that facilitates the removal of these bricks from the wall,” Edwards noted. “The outer membrane doesn’t collapse entirely; it doesn’t fall off. However, there are observable gaps that allow the antibiotic to access the inner membrane.”

The researchers also identified a critical reason for the antibiotic’s variable efficacy: it predominantly affects bacteria that are actively growing. In contrast, when bacteria enter a dormant state—often as a survival tactic against environmental challenges like nutrient shortages—polymyxin B loses its effectiveness because the bacteria halt armour production.

Progressive exposure of E. coli to polymyxin B demonstrating membrane changes over time

Images showing the changes to the outer layer of E. coli exposed to polymyxin B over time, from untreated to 90 minutes post-exposure.

Carolina Borrelli, Edward Douglas et al. / Nature Microbiology

Interestingly, the researchers found that supplying sugars to dormant E. coli cells could spur them back into activity, resuming lipopolysaccharide construction, and leaving them vulnerable to polymyxin B within just 15 minutes. This phenomenon may also apply to polymyxin E, the other polymyxin in clinical use.

Edwards suggests that while targeting dormant bacteria with sugars to reawaken them could be a strategy, it comes with risks, as it may lead to rapid bacterial proliferation at infection sites. Instead, he proposes exploring combination therapies that could bypass the dormant state without triggering increased bacterial growth.

Topics:

TAGGED:AntibioticcoliCommonextraordinaryPicturesShow
Share This Article
Twitter Email Copy Link Print
Previous Article ‘Mid-Century Modern’ Canceled After One Season at Hulu ‘Mid-Century Modern’ Canceled After One Season at Hulu
Next Article Fetterman rejects ‘Nazi,’ ‘fascist’ labels for opponents while affirming loyalty to the Democrats Fetterman rejects ‘Nazi,’ ‘fascist’ labels for opponents while affirming loyalty to the Democrats
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Europe’s Extremely Large Telescope Faces a New Dire Threat

The clash between the astronomical community and the renewable energy sector in northern Chile has…

January 30, 2025

Argentina farmers focus on harvest over sales despite currency boost

Argentina's grain industry has reacted positively to the recent exchange-rate overhaul implemented by the central…

April 15, 2025

‘Surreal’: Charlie Kirk Memorial Service Podium Enclosed in Bulletproof Glass for Speeches From Trump, JD Vance and Pete Hegseth — ‘Something Rarely Seen at an Indoor Event’

September 21, 2025, Published 5:50 p.m. ET Add Radar on Google Article continues below advertisement…

September 22, 2025

Facing Slower Growth, Health Insurer Centene Pulls 2025 Profit Outlook

Health insurer Centene, a major provider of individual coverage under the Affordable Care Act (ACA),…

July 1, 2025

Form3, a quiet giant in UK fintech, raises $60M at a $570M valuation

Form3 Secures $60 Million in Funding to Revolutionize Financial Transactions The global economy is facing…

September 10, 2024

You Might Also Like

In a First, Pig Liver Helped a Cancer Patient Survive for More Than a Month
Tech and Science

In a First, Pig Liver Helped a Cancer Patient Survive for More Than a Month

October 10, 2025
Canary Islands’ VFX Studios Hit Global Stage With Work on ‘The Accountant 2,’ ‘The Morning Show’ and ‘Gangs of London’
Entertainment

Canary Islands’ VFX Studios Hit Global Stage With Work on ‘The Accountant 2,’ ‘The Morning Show’ and ‘Gangs of London’

October 10, 2025
Sony Pictures Television Unveils ‘Trainer Games,’ Sells ‘The Miniature Wife’ and Adds ‘Hot Seat,’ ‘Shark Tank,’ ‘Carlota’ to Mipcom Slate (EXCLUSIVE)
Entertainment

Sony Pictures Television Unveils ‘Trainer Games,’ Sells ‘The Miniature Wife’ and Adds ‘Hot Seat,’ ‘Shark Tank,’ ‘Carlota’ to Mipcom Slate (EXCLUSIVE)

October 10, 2025
Want to See the Best Fall Colors This Year? Science Has the Answer
Tech and Science

Want to See the Best Fall Colors This Year? Science Has the Answer

October 10, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?